Aging Population and High Prevalence of Chronic Diseases Drive Demand for Clinical Nutrition Products, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Clinical Nutrition Products markets. Global market for Clinical Nutrition Products is projected to reach US$46 billion by 2018, driven by rising nutrient requirements among the elderly and the chronically ill patients.

Clinical Nutrition Products: A Global Strategic Business Report

Follow us on LinkedIn – Clinical nutrition is critical for patients who are unable to consume normal food, as nutritional deficiency caused by underlying disease condition enhances the risk of complications, lengthens recovery period, lowers quality of life, and increases risk of mortality. By providing the required amounts of essential nutrients such as proteins, vitamins and minerals to patients, clinical nutrition products aid in improving metabolism, digestion, absorption, and discharge functions that are critical for normal functioning of the body. Clinical nutrition products are extremely important for patients in intensive care units, patients suffering from chronic illnesses, patients recuperating from trauma and surgeries, or patients with high degree of malnourishment. Recovering market conditions and rising disposable income levels are driving demand in the market. The market is also benefiting from the rising investments in R&D for developing innovative products with improved nutritional attributes. Technological innovations and automation have also made it possible to administer clinical nutrition therapies at home without the aid of a trained professional. Development of lighter and simpler medical devices used for administering enteral and parenteral nutrition therapies, in both adults and children, is also playing an instrumental role in fuelling market growth.

As stated by the new market research report on Clinical Nutrition Products, the United States represents the largest market worldwide. Technological advancements associated with administration equipment, development of newer and nutritionally richer ingredients, use of parenteral and enteral nutrition products in alternative settings such as homecare, along with improvements in safety and effectiveness of clinical nutrition procedures, are key factors driving growth in the market. Asia-Pacific is forecast to spearhead growth with the fastest CAGR of 10.3% over the analysis period. Growth in the region is led by steady economic growth, better access to healthcare facilities, increase in private insurance coverage for clinical nutrition products, increasing per capita healthcare spends, and rise in home patient care.

Infant nutrition is the largest and fastest growing product category in the global clinical nutrition products market. Advancing maternal age and the ensuing rise in pre-term births and product innovations aimed at increasing the nutritional value and convenience of products are fuelling sales in this category. Growth is also attributed to rising demand for safe, high quality, nutrition products engineered to meet the nutrition requirements of growing babies. Europe represents the largest market for infant nutrition.

Enteral nutrition products are often prescribed to patients with a functional gastrointestinal tract but who are unable to consume food through the oral route. Development of disease-specific nutrient formulations is benefiting sales of enteral nutrition products. Key benefits of enteral nutrition driving its adoption include cost-effectiveness, safety and convenience of administration with minimal patient discomfort. Parenteral nutrition, on the other hand, is prescribed to patients who lack a functional gastrointestinal system or to infants with underdeveloped GI tracts.

Major players covered in the report include Abbott Nutrition, Ajinomoto Co Inc., American HomePatient Inc., Baxter International Inc., B. Braun Melsungen AG, Claris Lifesciences Ltd., Groupe Danone, Nutricia North America, Fresenius Kabi AG, Hospira Inc., Mead Johnson Nutrition Company, Meiji Co. Ltd., Nestlé Health Science S.A, Nestlé HealthCare Nutrition, Otsuka Pharmaceutical Factory Inc., Sino-Swed Pharmaceutical Corp Ltd. and The H. J. Heinz Company. among others.

The research report titled “Clinical Nutrition Products: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the market, industry overview, trends, growth drivers, latest product launches and recent industry activity. The report provides market estimates and projections for major geographic markets analyzed including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East/Africa and Latin America (Brazil, Mexico, and Rest of Latin America). Product segments analyzed include Enteral Nutrition, Infant Nutrition and Parenteral Nutrition.

For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Clinical_Nutrition_Products_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website